Literature DB >> 17043663

Proteomic identification of the wt-p53-regulated tumor cell secretome.

F W Khwaja1, P Svoboda, M Reed, J Pohl, B Pyrzynska, E G Van Meir.   

Abstract

Tumor-stroma interactions play a major role in tumor development, maintenance and progression. Yet little is known on how the genetic alterations that underlie cell transformation elicit cell extrinsic changes modulating heterotypic cell interactions. We hypothesized that these events involve a modification in the complement of secreted proteins by the cell, acting as mediators of intercellular communication. To test this hypothesis, we examined the role of wt-p53, a major tumor suppressor, on the tumor microenvironment through its regulation of secreted factors. Using a combination of 2-DE and cICAT proteomic techniques, we found a total of 111 secreted proteins, 39 of which showed enhanced and 21 inhibited secretion in response to wt-p53 expression. The majority of these were not direct targets of p53 transcription factor activity, suggesting a novel role for wt-p53 in the control of intracellular protein trafficking and/or secreted protein stability. Evidence for p53-controlled post-translational modifications on nine secreted proteins was also found. These findings will enhance our understanding of wt-p53 modulated interactions of the tumor with its environment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043663     DOI: 10.1038/sj.onc.1209969

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  An enhanced mass spectrometry approach reveals human embryonic stem cell growth factors in culture.

Authors:  Sean C Bendall; Chris Hughes; J Larry Campbell; Morag H Stewart; Paula Pittock; Suya Liu; Eric Bonneil; Pierre Thibault; Mickie Bhatia; Gilles A Lajoie
Journal:  Mol Cell Proteomics       Date:  2008-10-20       Impact factor: 5.911

2.  E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis.

Authors:  Ju Liu; C Zhang; X L Wang; P Ly; V Belyi; Z Y Xu-Monette; K H Young; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

Review 3.  Proteomics of gliomas: initial biomarker discovery and evolution of technology.

Authors:  Juliya Kalinina; Junmin Peng; James C Ritchie; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2011-09       Impact factor: 12.300

Review 4.  Contribution of p53 to metastasis.

Authors:  Emily Powell; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-03-21       Impact factor: 39.397

5.  Senescence-associated exosome release from human prostate cancer cells.

Authors:  Brian D Lehmann; Matthew S Paine; Adam M Brooks; James A McCubrey; Randall H Renegar; Rong Wang; David M Terrian
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; J Andrew Carlson; Agnes Noel; Jean-Michel Foidart; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Oncol       Date:  2010-03-01       Impact factor: 4.375

Review 7.  Methodologies to decipher the cell secretome.

Authors:  Paromita Mukherjee; Sridhar Mani
Journal:  Biochim Biophys Acta       Date:  2013-01-31

Review 8.  Cancer and the tumor microenvironment: a review of an essential relationship.

Authors:  Flaubert Mbeunkui; Donald J Johann
Journal:  Cancer Chemother Pharmacol       Date:  2008-12-14       Impact factor: 3.333

Review 9.  Involvement of stromal p53 in tumor-stroma interactions.

Authors:  Jair Bar; Neta Moskovits; Moshe Oren
Journal:  Semin Cell Dev Biol       Date:  2009-11-13       Impact factor: 7.727

10.  Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.

Authors:  Leonid Tarassishin; Jihyeon Lim; D Brent Weatherly; Ruth H Angeletti; Sunhee C Lee
Journal:  J Proteomics       Date:  2014-02-04       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.